News Related to Bloating

Related coverage linked through entity extraction aliases.

Bariatric Surgery Declines 46% as GLP-1 Obesity Drug Prescriptions Surge to 24% of Eligible Adults

Mar 13, 2026

Bariatric surgery procedures have fallen 46.4% since 2022 as prescriptions for semaglutide and tirzepatide rose to 24.17% of eligible adults by Q3 2025, though 75.8% of eligible patients still receive no treatment.

GLP-1 Weight Loss Injections Show Significant Results in Clinical Studies

Feb 14, 2026

Clinical studies demonstrate GLP-1 receptor agonists like semaglutide and tirzepatide produce substantial weight loss when combined with lifestyle changes, with patients achieving mean reductions of 14.9% body weight over 68 weeks.